left-caret
Insights

international regulatory enforcement

CFIUS Extends its Reach to Order the Termination of Ekso Bionics' Role in Joint Venture in China

June 10, 2020

By David Wang, Shaun Wu, Scott Flicker & Quinn Dang

On May 20, 2020, Ekso Bionics Holdings, Inc. (“Ekso Bionics”), a U.S. manufacturer of robotic mechanical suits (“exoskeletons”), announced that it had received an ultimatum from the Committee on Foreign Investment in the United States (“CFIUS” or the “Committee”) to terminate its role in a 2019 joint venture with Chinese partners.